Last $32.71 USD
Change Today -1.64 / -4.77%
Volume 383.6K
SPNC On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

spectranetics corp (SPNC) Snapshot

Open
$34.12
Previous Close
$34.35
Day High
$34.49
Day Low
$32.68
52 Week High
12/8/14 - $35.56
52 Week Low
05/7/14 - $20.07
Market Cap
1.4B
Average Volume 10 Days
452.0K
EPS TTM
$-0.35
Shares Outstanding
41.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SPECTRANETICS CORP (SPNC)

Related News

No related news articles were found.

spectranetics corp (SPNC) Related Businessweek News

No Related Businessweek News Found

spectranetics corp (SPNC) Details

The Spectranetics Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes single-use medical devices used in minimally invasive procedures in the cardiovascular system. Its products are used to treat arterial blockages in the legs and heart, and to remove pacemaker and defibrillator cardiac leads. The company's vascular intervention product line includes peripheral atherectomy, a range of laser catheters for ablation of blockages in arteries above and below the knee; crossing solutions, which support catheters to facilitate crossing of peripheral and coronary arterial blockages, and retrograde access and guidewire retrieval devices used in the treatment of peripheral arterial blockages, including chronic total occlusions; and coronary atherectomy and thrombectomy, which are aspiration and cardiac laser catheters for the treatment of blockages in the heart. Its primary vascular intervention products include the Turbo Elite and Turbo-Tandem laser catheters and the TAPAS drug delivery catheters for peripheral atherectomy; crossing catheters, such as the Quick-Cross, Quick-Cross Select, and Quick-Cross Extreme; the ELCA Laser Ablation Catheter for coronary atherectomy; and QuickCat aspiration catheter for thrombus management. The company's lead management product line comprises excimer laser sheaths, non-laser sheaths, and cardiac lead management accessories, such as Spectranetics Laser Sheath, GlideLight, and Lead Locking Device for the removal of pacemaker and defibrillator cardiac leads. It sells its products in the United States, Canada, Europe, the Middle East, the Asia Pacific, Latin America, and Puerto Rico. The Spectranetics Corporation was founded in 1984 and is headquartered in Colorado Springs, Colorado.

575 Employees
Last Reported Date: 09/5/14
Founded in 1984

spectranetics corp (SPNC) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $596.9K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $316.2K
Chief Operating Officer
Total Annual Compensation: $265.6K
Senior Vice President and General Counsel
Total Annual Compensation: $238.9K
Senior Vice President of Sales & Marketing fo...
Total Annual Compensation: $176.0K
Compensation as of Fiscal Year 2013.

spectranetics corp (SPNC) Key Developments

The Spectranetics Corporation Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 03:00 PM

The Spectranetics Corporation Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 03:00 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Scott William Drake, Chief Executive Officer, President and Director.

The Spectranetics Corporation Provides Earnings Guidance for Fiscal 2015

The Spectranetics Corporation provided earnings guidance for fiscal 2015. The company expects 2015 revenue to rise about 28% to a range of $258 million to $265 million, an increase of 28% to 30% over the company's 2014 estimate of $202.0 million to $203.5 million. The company estimates about $15-$20 million in ISR-related revenue in 2015. The net loss is projected to be in the range of $28.0 million to $32.0 million, or $0.66 to $0.75 per share. Non-GAAP net loss is projected to be in the range of $4.3 million to $8.3 million, or $0.10 to $0.20 per share.

The Spectranetics Corporation Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-03-2014 12:30 PM

The Spectranetics Corporation Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-03-2014 12:30 PM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SPNC:US $32.71 USD -1.64

SPNC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ABIOMED Inc $51.74 USD -0.51
AtriCure Inc $19.84 USD -0.51
Cardiovascular Systems Inc $34.09 USD -1.76
Endologix Inc $13.93 USD -0.44
Vascular Solutions Inc $27.26 USD -1.82
View Industry Companies
 

Industry Analysis

SPNC

Industry Average

Valuation SPNC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7.5x
Price/Book 7.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SPECTRANETICS CORP, please visit www.spectranetics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.